     

 

   

5%;
le -- (J - 6 ,
()qu row/WW; 8rd (muck/U in“ My“;

  

UUID : 7BS7FD81 -AMZ -LC76-BF65 -OBA233451065
TCGA-AS-ADGQ-D

mummmmlummmmiiiiimuImIiniiﬁiiiliied

IHlllHlllllllllllllllllllllﬂllllllllllllll
Ill llllllllllllllllllllllllllllllllllllll llllllll‘l‘l'lilllmllmm

v , i, [d
.53&:;«MiMW (3511 83", I‘M 11)”);

 

Ordering M.l).:

3 Copies To:
age/aexw-I— ASSISlanIZ
Location: Date of Procedure:
Date Received:

 

SURGICAL PATHOLOGY REPORT

DIAGNOSIS:

A. LEFT TUBE AND OVARY, SALPINGO—OOPHORECTOMY
- Ovary with no signiﬁcant pathologic change
- Fallopian tube with paratubal cyst; negative for malignancy

B. RIGHT TUBE AND OVARY, SALPINGO-OOPHORECTOMY
- Ovary with mild cystadenofibromatous changes; negative for malignancy
- Fallopian tube with paratubal cyst; negative for malignancy

C. UTERUS AND CERVIX, HYSTERECTOMY
Cervix
- Negative for malignancy

- Tunnel clusters and lobular endocervical hyperplasia
Endometrium

- Adenocarcinoma of the endometrium, endometrioid type, FIGO grade I of III

- Arising in a background of complex atypicalendometrial hyperplasia
Myometrium and serosa

- Endometrioid adenocarcinoma myoinvasive to approximately one-half of myometrium
- No angiolymphatic invasion identiﬁed

- Adenomyosis

- Serosa negative for malignancy

- AJCC Pathologic Stage (2002, 6'h Ed): pTlc/pNO

D. RIGHT PELVIC LYMPH NODE, EXCISION
- One lymph node negative for malignancy (1)

E. LEFT PELVIC LYMPH NODE, EXCISION
— One lymph node negative for malignancy (1)

HISTORY: Endometrial carcinoma

MICROSCOPIC:
See diagnosis.

GROSS:
A. LEFT TUBE AND OVARY

Labeled with the patient's name, labeled "left tube and ovary", and received in formalin is a salpingo—oophorectomy
specimen including a yellow, 1.4 x 0.3 x 0.3 cm ovary and a portion ofﬁmbriated fallopian tube which is 3.0 cm in
length x 0.3 cm in diameter. A small 0.4 cm in greatest dimension paratubal cyst is identiﬁed. On sectioning no
gross lesions are identiﬁed. Representative sections are submitted.

Patient Case(s):
Local

Page I of 2

 

PATIENT NOTIFIED OF RESULTS
DR: NURSE; DATE:

 

 

 

 

 

 

 

mm #= —

Al. Ovary - 2
A2. Fallopian tube ~ 3

B. RIGHT TUBE AND OVARY

Labeled with the patient's name, labeled "right tube and ovary", and received in formalin is a salpingo—
oophorectomy specimen consisting of a yellow, ﬁrm ovary measuring 1.5 x 0.5 x 0.5 cm and a brown fallopian tube
measuring 8.0 cm in length x 0.2 cm in diameter. Representative sections are submitted.

Bl. Ovary - 2

82. Fallopian tube ~ 3

C. UTERUS AND CERVIX

Labeled with the patient's name, labeled "uterus and cervix", and received in formalin is a 39.6 gram hysterectomy
specimen consisting of a previously posteriorly opened uterus. The uterus measures 7.0 x 3.0 x 3.0 cm. The
ectocervix measures 1.8 x 0.5 cm. The external os measures 0.4 cm in diameter, and the endocervical canal

measures 1.0 cm in length and 0.4 cm in thickness. The endometrial cavity measures 3.0 cm in length x 0.5 cm in
width.

margin blue, posterior surgical margin black. Slide key:
C1. Anterior cervix - 1

C2. Posterior cervix - 1

C3. Anterior lower uterine segment - 1

C4. Posterior lower uterine segment - 1

C5. Left superior corpus - 1

C6. Right superior corpus - 1

D. RIGHT PELVIC LYMPH NODE

Labeled with the patient's name, labeled "right pelvic lymph node", and received in formalin is a single piece of
yellow fatty tissue measuring 2.5 x 1.5 x 0.8 cm. No lymph nodes are grossly identified. The specimen is entirely
submitted.

D1. 1

E. LEFT PELVIC

Labeled with the patient's name, labeled "left pelvic", and received in formalin is a single piece of yellow, lobulated,
fatty tissue measuring 2.0 x 1.5 x 0.8 cm. There is one grossly identiﬁable lymph node measuring 0.8 x 0.4 x 0.2
cm which is submitted.

El. 2

Gross dictated by

{ft/11‘s report includes immuno/tisroclremical test results. please note the following:
Numerous immunolristoc/zemical tests were developed and their performance characteristics determined by

Those immuno/ristoclremical tests have not been cleared or approved by the
US. Food and Drug Administration (FDA). and FDA approval is not required.

I have nersnnallv examined the specimen ianmrmad the results, reviewed the report and signed it electronically.

SURGICAL PATHOLOGY REPORT *"'"'

h...
)Iagnosts Discrepancy
Page 2 a! 2 ’rlmarv Tumor Slle Discrepancy
11PM Discrepancy
'riar Mallgnancy History
Mal/(inub .. ' 2 ' . __ ...... .

Yes No

 

 
   

 

